Molecular Diagnostics
Biomarkers Predict Lyme Disease Post-Treatment Prognosis
Testing and diagnosis of the earliest stages of Lyme Disease (LD) have proven to be difficult or unreliable. The universally accepted diagnostic test for LD is a positive enzyme-linked immunosorbent assay (ELISA) followed by a positive western blot for immunoglobulin M (IgM) and IgG. More...06 Dec 2022
Low Cost, Highly Sensitive Blood Test for Cancer Makes Regular Monitoring Affordable
Scientists have discovered a novel low-cost method of testing for cancers. Called the Heatrich-BS assay, the new test sequences clinical samples that have been heated in order to isolate cancer-specific signatures found in a patient’s blood. More...06 Dec 2022
Method Enables Targeted Profiling of Human Extrachromosomal DNA
Oncogene amplification is a key cancer-driving mechanism and frequently occurs on circular extrachromosomal DNA (ecDNA). ecDNA oncogene amplifications are present in half of human cancer types and up to one-third of tumor samples and are associated with poor patient outcomes. More...05 Dec 2022
ctDNA-Based MRD Test to Detect As Few As One Mutant Molecule in a Million DNA Molecules
A best-in-class personalized cancer diagnostic test that is currently under development and planned for 2023 commercialization can detect as few as one mutant molecule in a million DNA molecules, positioning it as the most sensitive ctDNA-based MRD test for use in solid tumors. More...02 Dec 2022
Study Identifies Optimal Blood Tests for Detection and Treatment of Early Stage Alzheimer’s
A new study has identified which blood tests are best at detecting Alzheimer’s disease during the earliest stages, and also another blood test that is optimal for detecting relevant treatment effects. These findings will speed up the development of new therapies that can slow down the disease progression. More...02 Dec 2022
Blood Test for Protein Biomarker Could Detect Pancreatic Cancer at Very Early Stage
A new study has found that in some people diagnosed with pancreatic cancer, levels of a particular substance in their blood can be seen to start rising slowly as early as two years before the cancer was diagnosed. This raises the possibility for future research to find ways to detect the dreaded cancer earlier. More...02 Dec 2022
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
New
Silver Member
Quality Control Material
Multichem ID-B
New
Modular Hemostasis Automation Solution
CN Track
In Other News
Blood Tests Could Predict Survival Odds for Patients with Metastatic Cancer
New Serological Test Could Search for Viral Triggers of Diseases
Blood-Based NIPS Test Improves Access to Genetic Testing
Two Tau Variants Distinguish Corticobasal Degeneration from Other Tauopathies
First-Ever Blood Test Could Detect Deadly Heart Inflammation Within Hours
Urine-Based, Non-Invasive Molecular Test Accurately Detects Bladder Cancer
Altered Ratios of p53 Isoforms Predict Response of Breast Tumors to Chemotherapy
Benchtop Immunoanalyzer Delivers Lab Quality Results for Cardiology, Intensive Care and Emergency Wards at POC
Blood Test Could Screen for Changes in Proteins Prior to Breast Cancer Diagnosis
Tumor Biopsies Analysis Performed on Newly-diagnosed B-cell Neoplasms
Acute COVID-19 Infections Are Characterized by Elevated Blood Levels of IL-26
New Tool Assesses Cost of ctDNA Testing
Multiplex Vaginal Panel Identifies Three Distinct Conditions in One Hour
Novel Assay Enables Simultaneous Detection of SMA and SCID in Newborns
Simple Blood Test Could More Than Double Liver Cancer Detection Rate in High-Risk Population
First-Ever Saliva-Based Concussion Test to Be Available in 2023
AI Blood Test Detects Liver Cancer
Non-Invasive Saliva Test Predicts Future Risk for Alzheimer's
A Urine Test for Detection and Management of Cystic Fibrosis
Gene Signature Identifies Patients with Long-term Lyme Disease
Direct Real-Time PCR Protocol Detects Monkeypox Virus
Handheld Diagnostic Lab Offers POC Solution for Future Pandemics
Three-Protein Signature Blood Test Can Detect Undiagnosed Prediabetes
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
